{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:36:10Z","timestamp":1791894970801,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Veterinary Cardiology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.jvc.2008.12.001","type":"journal-article","created":{"date-parts":[[2009,4,25]],"date-time":"2009-04-25T10:03:12Z","timestamp":1240653792000},"page":"S51-S61","source":"Crossref","is-referenced-by-count":87,"special_numbering":"S1","title":["Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats"],"prefix":"10.1016","volume":"11","author":[{"given":"Philip R.","family":"Fox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri C.","family":"DeFrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce W.","family":"Keene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clark E.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin A.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten E.","family":"Schober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Bonagura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Stepien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi B.","family":"Kellihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaibinh P.","family":"Nguyenba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda B.","family":"Lehmkuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie K.","family":"Lefbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Sydney","family":"Moise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvc.2008.12.001_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/HCO.0b013e3282f43039","article-title":"Biomarkers in heart failure management","volume":"23","author":"Isaac","year":"2008","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jvc.2008.12.001_bib2","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMra0800239","article-title":"Biomarkers in heart failure","volume":"358","author":"Braunwald","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2008.12.001_bib3","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jacc.2007.02.037","article-title":"ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure","volume":"49","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2008.12.001_bib4","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/archinte.164.18.1978","article-title":"A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure","volume":"164","author":"Doust","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jvc.2008.12.001_bib5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1503\/cmaj.060236","article-title":"Natriuretic peptides in the diagnosis and management of heart failure","volume":"175","author":"Felker","year":"2006","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jvc.2008.12.001_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","article-title":"Natriuretic peptides","volume":"339","author":"Levin","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvc.2008.12.001_bib7","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0140-6736(96)07424-7","article-title":"The natriuretic-peptide family","volume":"349","author":"Wilkins","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jvc.2008.12.001_bib8","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1172\/JCI118162","article-title":"Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an \u201cemergency\u201d cardiac hormone against ventricular overload","volume":"3","author":"Nakagawa","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jvc.2008.12.001_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejheart.2004.04.012","article-title":"B-type natriuretic peptide and its precursor in cardiac venous blood from failing hearts","volume":"7","author":"Goetze","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jvc.2008.12.001_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2265.1997.2361058.x","article-title":"Espiner EA Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP): a new marker of cardiac impairment","volume":"47","author":"Hunt","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jvc.2008.12.001_bib11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clinbiochem.2007.08.008","article-title":"Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: a systematic review","volume":"41","author":"Worster","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jvc.2008.12.001_bib12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study","volume":"95","author":"Januzzi","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvc.2008.12.001_bib13","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/CIRCULATIONAHA.106.666255","article-title":"N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study","volume":"115","author":"Moe","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2008.12.001_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1939-1676.2003.tb02430.x","article-title":"Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure","volume":"17","author":"MacDonald","year":"2003","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2008.12.001_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1760-2734(06)70002-9","article-title":"Relationship between different natriuretic peptides and severity of naturally acquired mitral regurgitation in dogs with chronic myxomatous valve disease","volume":"2","author":"H\u00e4ggstr\u00f6m","year":"2000","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2008.12.001_bib16","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2460\/javma.232.10.1496","article-title":"Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity","volume":"232","author":"Oyama","year":"2008","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2008.12.001_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1939-1676.2007.tb02956.x","article-title":"Prospective clinical evaluation of an ELISA B-type natriuretic peptide assay in the diagnosis of congestive heart failure in dogs presenting with cough or dyspnea","volume":"21","author":"DeFrancesco","year":"2007","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2008.12.001_bib18","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2460\/javma.232.11.1674","article-title":"Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease","volume":"232","author":"Fine","year":"2008","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2008.12.001_bib19","series-title":"Respiratory disease in dogs and cats","first-page":"12","article-title":"Respiratory distress in cats","author":"Mandell","year":"2004"},{"key":"10.1016\/j.jvc.2008.12.001_bib20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1939-1676.2007.tb03012.x","article-title":"Diagnostic accuracy of electrocardiography and thoracic radiography in the assessment of left atrial size in cats: comparison with transthoracic 2-dimensional echocardiography","volume":"21","author":"Schober","year":"2007","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2008.12.001_bib21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2460\/javma.2002.220.202","article-title":"Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990\u20131999)","volume":"220","author":"Rush","year":"2002","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2008.12.001_bib22","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/01.CIR.92.9.2645","article-title":"Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy. An animal model of human disease","volume":"92","author":"Fox","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2008.12.001_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1939-1676.2007.0007.x","article-title":"Evaluation of plasma C-terminal atrial natriuretic peptide in healthy cats and cats with heart disease","volume":"22","author":"Hori","year":"2008","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2008.12.001_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1939-1676.2006.tb02858.x","article-title":"N-terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy","volume":"20","author":"MacLean","year":"2006","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2008.12.001_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1354\/vp.40-5-501","article-title":"Immunohistochemistry of atrial and brain natriuretic peptides in control cats and cats with hypertrophic cardiomyopathy","volume":"40","author":"Biondo","year":"2003","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jvc.2008.12.001_bib26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1939-1676.2007.0024.x","article-title":"Circulating natriuretic peptides in cats with heart disease","volume":"22","author":"Connolly","year":"2008","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2008.12.001_bib27","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1939-1676.2006.tb00707.x","article-title":"The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure","volume":"20","author":"MacDonald","year":"2006","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2008.12.001_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1939-1676.1993.tb01015.x","article-title":"Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine","volume":"7","author":"Thomas","year":"1993","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2008.12.001_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2460\/ajvr.2003.64.93","article-title":"Comparison between invasive hemodynamic measurements and noninvasive assessment of left ventricular diastolic function by use of Doppler echocardiography in healthy anesthetized cats","volume":"64","author":"Schober","year":"2003","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jvc.2008.12.001_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1939-1676.2004.tb02604.x","article-title":"Echocardiographic estimation of mean left atrial pressure in a canine model of acute mitral valve insufficiency","volume":"18","author":"Oyama","year":"2004","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2008.12.001_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2460\/javma.2000.216.210","article-title":"Vertebral scale system to measure heart size in radiographs of cats","volume":"216","author":"Litster","year":"2000","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2008.12.001_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1760-2734(06)70061-3","article-title":"Endomyocardial fibrosis and restrictive cardiomyopathy: pathologic and clinical features","volume":"6","author":"Fox","year":"2004","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2008.12.001_bib33","series-title":"Textbook of canine and feline cardiology principals and practice","first-page":"621","article-title":"Feline cardiomyopathies","author":"Fox","year":"1999"},{"key":"10.1016\/j.jvc.2008.12.001_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1748-5827.2007.00510.x","article-title":"The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease","volume":"49","author":"Boswood","year":"2008","journal-title":"J Small Animal Pract"},{"key":"10.1016\/j.jvc.2008.12.001_bib35","first-page":"1557","article-title":"Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy hypertrophic cardiomyopathy","volume":"23","author":"Brito","year":"2004","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.jvc.2008.12.001_bib36","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1136\/hrt.2007.126748","article-title":"B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy","volume":"94","author":"Kaski","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jvc.2008.12.001_bib37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10554-007-9256-2","article-title":"The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients","volume":"24","author":"Ceyhan","year":"2008","journal-title":"Int J\u00a0Cardiovasc Imaging"},{"key":"10.1016\/j.jvc.2008.12.001_bib38","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehi406","article-title":"The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements","volume":"26","author":"Tsch\u00f6pe","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvc.2008.12.001_bib39","first-page":"344","article-title":"Significance of brain natriuretic peptide in the evaluation of symptoms and the degree of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy","volume":"47","author":"Panou","year":"2006","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.jvc.2008.12.001_bib40","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ahj.2005.02.045","article-title":"Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy","volume":"150","author":"Arteaga","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvc.2008.12.001_bib41","first-page":"46","article-title":"Serum NT pro-BNP: relation to systolic and diastolic function in cardiomyopathies and pericardiopathies","volume":"911","author":"Mady","year":"2008","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jvc.2008.12.001_bib42","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0735-1097(98)00045-X","article-title":"Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis","volume":"31","author":"Takemura","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2008.12.001_bib43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1527-5299.2007.06478.x","article-title":"Factors determining extreme brain natriuretic peptide elevation","volume":"13","author":"Guglin","year":"2007","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jvc.2008.12.001_bib44","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/00004872-200018080-00018","article-title":"Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population","volume":"18","author":"Luchner","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.jvc.2008.12.001_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jacc.2005.08.051","article-title":"Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study","volume":"47","author":"Anwaruddin","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2008.12.001_bib46","first-page":"1511","article-title":"Natriuretic peptides in chronic kidney disease","volume":"53","author":"Tagore","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jvc.2008.12.001_bib47","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1373\/clinchem.2006.084533","article-title":"Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality","volume":"53","author":"deFilippide","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.jvc.2008.12.001_bib48","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.amjcard.2008.03.082","article-title":"Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic peptide in patients with heart failure with versus without chronic kidney disease","volume":"102","author":"Bruch","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvc.2008.12.001_bib49","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1161\/01.CIR.96.9.2953","article-title":"Circulating cardiac troponin I in severe congestive heart failure","volume":"96","author":"Missov","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2008.12.001_bib50","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/01.CIR.0000084543.79097.34","article-title":"Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure","volume":"108","author":"Horwich","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2008.12.001_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1098-612X(03)00007-X","article-title":"Cardiac troponin I in cats with hypertrophic cardiomyopathy","volume":"5","author":"Connolly","year":"2003","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.jvc.2008.12.001_bib52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcp\/110.2.241","article-title":"Cardiac troponin I and T alterations in dog hearts with myocardial infarction: correlation with infarct size","volume":"110","author":"Ricchiuti","year":"1998","journal-title":"Am J\u00a0Clin Pathol"},{"key":"10.1016\/j.jvc.2008.12.001_bib53","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s001340100920","article-title":"Elevation of troponin I in sepsis and septic shock","volume":"27","author":"Ammann","year":"2001","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jvc.2008.12.001_bib54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/qjmed\/hci055","article-title":"Pitfalls and problems of relying on serum troponin","volume":"98","author":"Burness","year":"2005","journal-title":"Q J Med"},{"key":"10.1016\/j.jvc.2008.12.001_bib55","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1751-0813.2008.00345.x","article-title":"Cardiac troponin I is elevated in dogs and cats with azotaemia renal failure and in dogs with non-cardiac systemic disease","volume":"86","author":"Porciello","year":"2008","journal-title":"Aust Vet J"},{"key":"10.1016\/j.jvc.2008.12.001_bib56","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2460\/javma.2002.221.381","article-title":"Serum cardiac troponin I and cardiac troponin T concentrations in dogs with gastric dilatation-volvulus","volume":"221","author":"Schober","year":"2002","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2008.12.001_bib57","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2460\/javma.233.8.1261","article-title":"Assessment of plasma cardiac troponin I concentration as a means to differentiate cardiac and noncardiac causes of dyspnea in cats","volume":"232","author":"Herndon","year":"2008","journal-title":"J Am Vet Med Assoc"}],"container-title":["Journal of Veterinary Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273409000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273409000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T22:49:13Z","timestamp":1710283753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1760273409000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":57,"alternative-id":["S1760273409000022"],"URL":"https:\/\/doi.org\/10.1016\/j.jvc.2008.12.001","relation":{},"ISSN":["1760-2734"],"issn-type":[{"value":"1760-2734","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}